KRAS and pancreatic neoplasm: Previous mutational analyses have shown that KRAS mutations are commonly detected in pancreatic juice sampled from patients with pancreatic cancer [9, 13, 27] or from persons undergoing screening because they are considered high-risk subjects [12, 14, 28, 29].